Search

Displaying results 4071 - 4080 of 10000 in total
  1. Drug

    Lefamulin

    go.drugbank.com/drugs/DB12825
    Approved

    [A183206] Lefamulin is available in intravenous and oral preparations and was granted FDA approval in August 2019.

  2. Drug

    Eprodisate

    go.drugbank.com/drugs/DB06405
    Investigational

    Eprodisate slows the decline of renal function in AA amyloidosis.

  3. Drug

    GTX-758

    go.drugbank.com/drugs/DB14969
    Investigational

    GTX-758 is under investigation in clinical trial NCT01420861 (GTx-758 on Serum Prostate-specific Antigen (PSA) in Men With Castrate Resistant Prostate Cancer).

  4. Drug

    Dodecyltrimethylammonium

    go.drugbank.com/drugs/DB02779
    Experimental

    Synonyms: N,N,N-Trimethyl-1-dodecanaminium, n-DodecyltrimethylammoniumCategories: Compounds used in a research, industrial, or household setting
  5. Drug

    Calcium oxide

    go.drugbank.com/drugs/DB15648
    Investigational

    Categories: Compounds used in a research, industrial, or household setting
  6. Drug

    VP025

    go.drugbank.com/drugs/DB05133
    Experimental

    VP025, a novel drug formulation based on phospholipid microparticles incorporating phosphatidylglycerol, can inhibit neuroinflammation.

  7. Drug

    Propatyl nitrate

    go.drugbank.com/drugs/DB13255
    Investigational

    Categories: Vasodilators Used in Cardiac Diseases
  8. Drug

    Terbutryn

    go.drugbank.com/drugs/DB08215
    Experimental

    Categories: Compounds used in a research, industrial, or household setting
  9. Drug

    Enalkiren

    go.drugbank.com/drugs/DB03395
    Experimental

    Categories: Agents Acting on the Renin-Angiotensin System
  10. Drug

    SPC2968

    go.drugbank.com/drugs/DB06351
    Investigational

    It was under investigation in clinical trial NCT02564614 (A Study of Hypoxia-inducible Factor 1a (HIF1A) Messenger Ribonucleic Acid (mRNA) Antagonist (RO7070179), to Demonstrate Proof-of-mechanism in Adult